Benign · CystICD-10 L72.0

Milia

Milium (singular) / milia (plural); "milk spots"; congenital milia (infantile); secondary / "post-traumatic" milia

Milia are small (1–3 mm), firm, dome-shaped, white-yellow superficial epidermal keratin-filled cysts. Two clinical contexts are recognised: primary milia (idiopathic, including infantile milia, the multiple eruptive milia of adolescence, and the milia en plaque variant) — generally appearing on the face (cheeks, eyelids, periorbital, forehead) of healthy individuals; and secondary milia — arising at sites of previous blistering disease (epidermolysis bullosa, porphyria cutanea tarda, bullous pemphigoid, second-degree burns), trauma (dermabrasion, chemical peel, laser resurfacing) or chronic topical corticosteroid use. Milia are entirely benign with no malignant potential. The skin-oncology relevance is twofold: (1) clinical confusion with sebaceous hyperplasia, syringoma, BCC, trichoepithelioma or other small facial tumours; and (2) the recognition that multiple milia in a young patient with other cutaneous features can be an early marker of Bazex-Dupré-Christol (with hypotrichosis, follicular atrophoderma, multiple BCCs), Rombo syndrome (with vermiculate atrophoderma), Brooke-Spiegler syndrome or rare congenital genodermatoses (Gardner syndrome, basaloid follicular hamartoma syndrome).

CurrentLast reviewed 26 April 2026
Clinical image of Milia
Milia. Image sourced from DermNet New Zealand. Used under CC BY-NC-ND 4.0. No endorsement implied.

Clinical features

  • Multiple small (1–3 mm), firm, dome-shaped, white to pearly-yellow superficial papules.
  • Distribution — face (cheeks, eyelids, periorbital, forehead, nose); occasionally chest, back, genitalia.
  • Asymptomatic; cosmetic concern is the principal presenting issue.
  • Primary milia:
    • Congenital / infantile milia — present at birth in 40–50% of full-term newborns; spontaneously resolve over weeks; nasal, perinasal, palatal (Epstein pearls).
    • Multiple eruptive milia — multiple new milia in adolescence / young adult.
    • Milia en plaque — clusters of milia within an erythematous plaque, classically post-auricular.
  • Secondary milia:
    • Following bullous disease — epidermolysis bullosa, porphyria cutanea tarda, bullous pemphigoid, epidermolysis bullosa acquisita (EBA), second-degree burns.
    • Following trauma — dermabrasion, chemical peel, laser resurfacing, cryotherapy, contact dermatitis healing.
    • Following chronic topical corticosteroid use.
    • Following radiotherapy.

Histology

  • Small (~1–2 mm) round superficial epidermal cyst with a thin stratified squamous epithelial wall (with granular layer) and a central keratin core.
  • Located in the superficial dermis (in contrast to epidermoid cysts which are deeper).
  • Usually arises from the infundibulum of the vellus hair follicle (primary milia) or from eccrine ducts / occluded follicles in damaged skin (secondary milia).
  • No atypia.

Syndromic associations

  • Multiple milia in a young patient with other cutaneous features — consider:
    • Bazex-Dupré-Christol syndrome — milia + congenital hypotrichosis + follicular atrophoderma of the dorsal hands + multiple early BCCs — see monograph.
    • Rombo syndrome — milia + vermiculate atrophoderma of the cheeks + hypotrichosis + peripheral cyanosis + multiple BCCs — see monograph.
    • Brooke-Spiegler syndrome — milia in the context of multiple cylindromas, spiradenomas and trichoepitheliomas — see monograph.
    • Gardner syndrome — multiple epidermoid cysts (sometimes with milia) in unusual sites + osteomas + colorectal polyposis (FAP) — see epidermoid cyst page.
    • Basaloid follicular hamartoma syndrome — multiple basaloid follicular hamartomas + milia + alopecia.
    • Atrichia with papular lesions — milia-like papules + alopecia.
    • Congenital epidermolysis bullosa — bullous skin + multiple secondary milia at healed blister sites.

Management

  • Reassurance — typical milia are benign and often spontaneously resolve (especially infantile).
  • Removal options (cosmetic):
    • Incision and expression with a hypodermic needle — first-line for individual milia; quick, simple, leaves no scar.
    • Curettage with electrodesiccation.
    • Cryotherapy.
    • Topical retinoids (tretinoin) — for multiple eruptive milia; reduces formation rate.
    • Oral retinoids (isotretinoin) — refractory multiple milia.
    • CO₂ laser ablation — milia en plaque.
  • Histology unnecessary for typical milia; biopsy if any diagnostic doubt or syndromic context.
  • Identify and treat any underlying bullous disease, drug, trauma or syndromic context.

References

  1. Berk DR, Bayliss SJ. Milia — a review and classification. J Am Acad Dermatol; 2008.
  2. Tsuruta D et al. Milia en plaque — review. J Am Acad Dermatol; 2008.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.